Matthew joined SVB in 2015 after 18 years as a General Partner of Oxford Bioscience Partners, an early stage life science venture capital firm which invested $1.1 Billion in 149 companies.
Oxford's representative investments include Human Genome Sciences, Exelixis, Illumina, Solexa, Genset, GeneLogic, Enanta, Xencor, Salix, Zone Labs, Strategene and BioSource.
On winter weekends, Matthew skis with his wife and twin daughters and on summer weekends he surfs and sails with his family on Nantucket.
Visit CipherBio at https://cipherbio.com.
See how SVB makes next happen now for entrepreneurs like you.